Volume 145, Issue 4, Pages e2 (October 2013)

Slides:

Advertisements

Similar presentations

Early Administration of Azathioprine Versus Conventional Management of Crohn’s Disease : A Randomized Controlled Trial F1. Ja Won Koo JACQUES COSNES, ANNE.

Advertisements

Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten- Free Diet Jacques Cosnes, Christophe Cellier, Sheila Viola, Jean–Frederic.

American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis Lisa L. Strate, Anne F. Peery, Ignacio.

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Volume 141, Issue 5, Pages e5 (November 2011)

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Volume 145, Issue 4, Pages e1 (October 2013)

Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten- Free Diet Jacques Cosnes, Christophe Cellier, Sheila Viola, Jean–Frederic.

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis Janneke van Grinsven, Sandra van Brunschot Gastroenterology

Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents Christine.

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy Jean–François Rahier, Sébastien.

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 147, Issue 4, Pages e7 (October 2014)

Volume 139, Issue 4, Pages e1 (October 2010)

Outcomes Among Living Liver Donors

Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study Masoud Solaymani–Dodaran,

Volume 154, Issue 1, Pages e6 (January 2018)

Volume 130, Issue 4, Pages (April 2006)

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents Pauline.

A 31-Year-Old Patient With Colitis and Perianal Disease

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy Christina Reimer, Bo Søndergaard, Linda.

Unusual Case of an Upset Stomach

Volume 155, Issue 4, Pages (October 2018)

Volume 135, Issue 5, Pages (November 2008)

Sang Pyo Lee, Hang Lak Lee, Kang Nyeong Lee Gastroenterology

Volume 153, Issue 3, Pages e16-e17 (September 2017)

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease Jean–Frédéric Colombel, William.

Volume 150, Issue 4, Pages (April 2016)

Natural History of Eosinophilic Gastroenteritis

American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis Lisa L. Strate, Anne F. Peery, Ignacio.

Volume 151, Issue 1, Pages e4 (July 2016)

Volume 155, Issue 2, Pages e10 (August 2018)

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled.

Miguel Regueiro, Kevin E. Kip, Leonard Baidoo, Jason M

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease

Laura Rotundo, Sushil Ahlawat Gastroenterology

Volume 136, Issue 1, Pages (January 2009)

Volume 146, Issue 4, Pages e2 (April 2014)

Efficient Early Drug Development for Ulcerative Colitis

Volume 142, Issue 1, Pages e5 (January 2012)

Volume 132, Issue 1, Pages (January 2007)

David H. Bruining, William J. Sandborn

Volume 135, Issue 5, Pages (November 2008)

A Selection of the Best AGA Abstracts of DDW 2017

Volume 133, Issue 2, Pages (August 2007)

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 151, Issue 1, Pages e4 (July 2016)

Antoine Debourdeau, Anne Bozon, Romain Altwegg Gastroenterology

Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab Guillaume Bouguen, Laurent Siproudhis, Emmanuel Gizard, Timothée Wallenhorst,

Volume 150, Issue 2, Pages e4 (February 2016)

Volume 150, Issue 7, Pages (June 2016)

Issue Highlights Clinical Gastroenterology and Hepatology

Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study William J. Sandborn, Stefan Schreiber,

A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease Vered Abitbol,

Ileal Peduculated Tumor in a Patient With Crohn's Disease

Volume 151, Issue 4, Pages (October 2016)

Volume 147, Issue 4, Pages (October 2014)

Volume 128, Issue 7, Pages (June 2005)

Volume 132, Issue 3, Pages (March 2007)

Christopher Hung, Desmond Leddin

Volume 139, Issue 6, Pages e1 (December 2010)

Epidemiology and Natural History of Inflammatory Bowel Diseases

Reinvesting in US Biomedical Research—The Time is Now

Electronic Clinical Challenges and Images in GI

Medical Therapy for Refractory Pediatric Crohn’s Disease

Presentation transcript:

Volume 145, Issue 4, Pages 758-765.e2 (October 2013) Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial Jacques Cosnes, Anne Bourrier, David Laharie, Stéphane Nahon, Yoram Bouhnik, Franck Carbonnel, Matthieu Allez, Jean–Louis Dupas, Jean–Marie Reimund, Guillaume Savoye, Pauline Jouet, Jacques Moreau, Jean–Yves Mary, Jean–Frédéric Colombel Gastroenterology Volume 145, Issue 4, Pages 758-765.e2 (October 2013) DOI: 10.1053/j.gastro.2013.04.048 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Proportion of patients who were treated with immunosuppressant therapy (including immunomodulators and anti-TNF) per trimester over time. All trimesters of follow-up are included. Gastroenterology 2013 145, 758-765.e2DOI: (10.1053/j.gastro.2013.04.048) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Proportion of patients in corticosteroid-free, anti-TNF–free remission per trimester over time. The concomitant proportions were significantly different only at trimester 3 (P < .05). Trimesters ended by a missing visit are excluded. Gastroenterology 2013 145, 758-765.e2DOI: (10.1053/j.gastro.2013.04.048) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Kaplan–Meier estimates of the time without CD-related perianal surgery. Gastroenterology 2013 145, 758-765.e2DOI: (10.1053/j.gastro.2013.04.048) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 1 Trial profile. Gastroenterology 2013 145, 758-765.e2DOI: (10.1053/j.gastro.2013.04.048) Copyright © 2013 AGA Institute Terms and Conditions